Hyliion 10-Q: $7.5M Q3 Revenue, $11.1M Net Loss, Reactor Fix Pushes Early Deliveries to 2027
HYLN has more than doubled off its 52-week low of $1.56.
Summary
Hyliion's Q3 10-Q shows revenue of $7.5 million against an $11.1 million net loss, with $121 million of cash and investments and a reactor redesign delaying early customer deliveries into early 2027.
Key Events · Earnings and Guidance · HYLN
-
Q3 Revenue Jumps to $7.5M
Third-quarter revenue reached $7.5 million versus $0.8 million a year earlier, all from ONR research and development services; gross profit was $0.6 million.
-
Net Loss Narrows to $11.1M
Q3 net loss was $11.1 million ($0.06 per share) versus $13.3 million a year ago; nine-month net loss was $36.7 million versus $44.0 million.
-
Cash and Investments of $121M
At September 30, 2026 the company held $16.7 million of cash and $104.7 million of investments, and projects roughly $115-120 million remaining at year-end 2026 assuming no ATM sales.
-
Reactor Issue Delays Deliveries
A reactor component susceptible to thermal fatigue was discovered in the second half of 2026; the ~10 early adopter units are now expected to be delivered between late 2026 and early 2027 rather than by end-2026.
Analysis · HYLN · Manufacturing
The 10-Q fills in the numbers behind this morning's guidance raise. Revenue jumped to $7.5 million from $0.8 million a year ago on ONR research contracts, yet the company still lost $11.1 million in the quarter and $36.7 million over nine months. The balance sheet is the real story: $16.7 million of cash plus $104.7 million of investments, with management projecting roughly $115-120 million remaining at year-end — enough runway that the new $100 million ATM is optional rather than urgent. The offsetting negative is operational: a reactor component prone to thermal fatigue has pushed the ~10 early adopter unit deliveries from 2026 into late 2026-early 2027, and a securities class action plus a derivative suit over the VFG Holdings letter of intent remain pending.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HYLN was trading at $3.13 on NYSE in the Manufacturing sector, with a market capitalization of approximately $534M. The 52-week trading range was $1.56 to $8.49. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.